FibroGen (Mexico) Today
| FGEN Stock | MXN 9.79 0.29 3.05% |
PerformanceOK
| Odds Of DistressAverage
|
FibroGen is trading at 9.79 as of the 17th of February 2025; that is 3.05 percent increase since the beginning of the trading day. The stock's open price was 9.5. FibroGen has 53 percent odds of going through some form of financial distress in the next two years but had a very ok returns during the last 90 days. The performance scores are derived for the period starting the 18th of January 2025 and ending today, the 17th of February 2025. Click here to learn more.
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company was incorporated in 1993 and is headquartered in San Francisco, California. FibroGen operates under Biotechnology classification in Mexico and is traded on Mexico Stock Exchange. The company has 93.96 M outstanding shares. More on FibroGen
Moving together with FibroGen Stock
| 0.64 | APA | APA Corporation Earnings Call This Week | PairCorr |
Moving against FibroGen Stock
FibroGen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. FibroGen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding FibroGen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
FibroGen (FGEN) is traded on Mexican Exchange in Mexico and employs 566 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 43.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate FibroGen's market, we take the total number of its shares issued and multiply it by FibroGen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. FibroGen operates under Healthcare sector and is part of Biotechnology industry. The entity has 93.96 M outstanding shares.
FibroGen has accumulated about 565.4 M in cash with (82.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.56.
Check FibroGen Probability Of Bankruptcy
Ownership AllocationFibroGen holds a total of 93.96 Million outstanding shares. The majority of FibroGen outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in FibroGen to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in FibroGen. Please pay attention to any change in the institutional holdings of FibroGen as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check FibroGen Ownership Details
FibroGen Risk Profiles
Although FibroGen's alpha and beta are two of the key measurements used to evaluate FibroGen's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.98 | |||
| Semi Deviation | 3.68 | |||
| Standard Deviation | 6.43 | |||
| Variance | 41.35 |
FibroGen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in FibroGen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
FibroGen Corporate Management
Elected by the shareholders, the FibroGen's board of directors comprises two types of representatives: FibroGen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of FibroGen. The board's role is to monitor FibroGen's management team and ensure that shareholders' interests are well served. FibroGen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, FibroGen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mr JD | Chief Officer | Profile | |
| Enrique Conterno | CEO Director | Profile | |
| Barry Berkowitz | Founder | Profile | |
| Christine Chung | VP Operations | Profile | |
| Elias Kouchakji | Drug Devel | Profile | |
| Juan Graham | Chief Officer | Profile | |
| Karen Bergman | VP Communications | Profile |
Additional Tools for FibroGen Stock Analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.